Search

everythinglearnresearchcommunity

for

Search:↓

Switching to extended-release divalproex sodium improved patient-reported tremor but did not change seizure frequency or most side effects.

The new drug carriers show promise for better targeting and treating ovarian cancer.

Testosterone increases fluid secretion and aquaporin expression in the vas deferens, which is important for male fertility.

Ablative fractional resurfacing could improve how well topical drugs penetrate the skin, but more research is needed to fine-tune the method.

A reliable method was developed to measure finasteride in hair products.

SPET-085 effectively inhibits an enzyme linked to prostate issues, similar to finasteride.

BOOST is a promising, easy-to-use treatment for diabetic foot ulcers that improves healing by reducing inflammation and promoting blood vessel growth.

Overexpressing ornithine decarboxylase and v-Ha-ras in keratinocytes leads to invasiveness and malignancy.

Nelfb is essential for dermal fat development and survival.

ELF5 is essential for skin cell growth and maintenance.

Presurgical models can effectively and affordably screen cancer prevention agents.

Keratinocyte gene expression is controlled by multiple modules with specific binding sites.

Deuruxolitinib significantly improves hair satisfaction in severe alopecia areata patients.

Increased TEMRA cells can predict treatment outcomes in rapidly progressive alopecia areata.

Increasing TSPO in the brain reduces anxiety and depression.

A new 3D breast tumor model helps test drug effects more accurately than traditional methods.

The N-K GM Series offers a new method to reduce aflatoxin poisoning and cancer, improving health and saving costs in affected regions.

ODC overexpression in hair cells increases tumor growth by reducing Notch signaling.

Increased ODC expression makes normally tumor-resistant mice more prone to tumor development.

The nanoparticles show promise for cancer treatment and diagnosis with fewer side effects.

Using protein degradation to fight cancer drug resistance shows promise but needs more precise targeting and fewer side effects.

For East Asians, using a deeper and larger punch in FUE is crucial to avoid follicle damage.

Continuous treatment with ritlecitinib and brepocitinib is needed to maintain hair regrowth in alopecia areata.

Removing both KLK5 and KLK7 proteins can prevent death and skin issues in Netherton syndrome.

Pexidartinib often causes liver issues and fatigue, especially in women.

Compound 7p shows strong potential as an anticancer agent.